1.Interpretation of advances in the treatment of non-small cell lung cancer at the 2025 World Conference on Lung Cancer (WCLC)
Bo BAO ; Jiayu LU ; Wen LIU ; Xuxu ZHANG ; Jiahe LI ; Jipeng ZHANG ; Wei LI ; Qiang LU
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery 2026;33(02):218-230
The 26th World Conference on Lung Cancer (WCLC) was held in Barcelona during September 6-9, 2025. As the world's largest and most influential academic meeting in the field of lung cancer, this year's congress unveiled long-term follow-up data from several pivotal studies and significant advances in novel therapeutic strategies. In the realm of targeted therapy, a next-generation combination strategy has been established as the new standard of care for the first-line treatment of patients with advanced epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC), demonstrating a significant improvement in overall survival. In immunotherapy, novel combination regimens have not only addressed the therapeutic challenge of acquired resistance to EGFR targeted therapies, but also shown clear long-term survival benefits in both the perioperative and locally advanced settings. These findings pave the way for shifting the treatment paradigm to earlier stages for patients with NSCLC. Antibody-drug conjugates have made remarkable strides in this field. They have shown outstanding efficacy in patients with specific resistance mutations and those with brain metastases, and have also demonstrated immense potential in treating patients with HER2-aberrant lung cancer and broader NSCLC populations. This offers new therapeutic options for patients with refractory lung cancer.However, significant challenges remain, including the heterogeneity of resistance mechanisms, the selection of optimal treatment regimens, and management strategies for special populations. Future research should focus on identifying novel precision biomarkers and optimizing therapeutic strategies to ultimately improve clinical outcomes for all patients with lung cancer.
2.Construction and practice of application model for localized large language model in preoperative medication reconciliation for gastric cancer
Yuxuan ZHU ; Jizhong ZHANG ; Yuhao SUN ; Jiayu WEN ; Xin LIU ; Jifu WEI ; Lingli HUANG
China Pharmacy 2026;37(8):1062-1067
OBJECTIVE To construct a preoperative medication reconciliation model assisted by a localized large language model (LLM) for gastric cancer and evaluate its clinical efficacy. METHODS A total of 249 gastric cancer patients with a history of continuous medication before admission in the Gastric Surgery Department of Jiangsu Cancer Hospital were retrospectively enrolled. Patients were divided into training set (154 cases) and validation set (95 cases) based on the order of time. Based on guidelines, drug package inserts, and other evidence, a standardized medication reconcili ation process and a structured knowledge base were constructed. DeepSeek-V3 LLM was deployed privately in the hospital, combined with retrieval-augmented generation technology, to achieve automated integration of medication information, risk screening, and generation of personalized recommendations. The quality of LLM-generated recommendations was evaluated using automatic metrics (BERT Score and ROUGE-1, 2, L) and manual scoring [seven-dimensional index (7DI) ] . Spearman correlation analysis was performed to explore the correlation between automatic scores and manual scores. Cronbach’s α coefficient was used to test the internal consistency of manual scoring results. The time consumed by manual and LLM-assisted medication reconciliation was compared across tasks of different difficulty levels (simple, moderate, and high). RESULTS A structured knowledge base covering 8 major drug categories was finally established, covering common and high-risk preoperative medication scenarios and providing structured retrieval support for the LLM. For automatic evaluation, the precision, recall, and F1-score of BERT Score were 0.783±0.033, 0.811±0.038, and 0.796±0.028, respectively. The F1-scores of ROUGE-1, ROUGE-2 and ROUGE-L were 0.566±0.067, 0.338±0.076 and 0.468±0.082, respectively. The 7DI scores from three manual raters ranged from 32.06 to 33.45. The F1-score of automatic scoring was significantly positively correlated with the 7DI score of manual scoring (maximum coefficient of determination=0.611, P <0.001), and the internal consistency of manual scoring was good (Cronbach’s α = 0.876). In terms of efficiency, LLM-assisted medication reconciliation reduced time consumption by more than 90% compared with manual reconciliation in the simple, moderate, and high-difficulty groups ( P <0.001). CONCLUSIONS The medication reconciliation model constructed based on a localized LLM and structured knowledge base shows high accuracy, consistency, and clinical applicability in complex preoperative medication scenarios for gastric cancer. It can improve the efficiency of medication reconciliation and reduce potential medication risks.
3.Effect of uric acid level and sugar sweetened beverage intake on elevated blood pressure among children and adolescents in Guangzhou
ZHANG Zehui, JI Jiting, LONG Jiayi, PAN Shun, MO Miaoling, LU Zhiqing, LI Boyuan, CHEN Jiayu, LIU Li
Chinese Journal of School Health 2026;47(6):878-882
Objective:
To investigate the association between uric acid level and elevated blood pressure among children and adolescents in Guangzhou, so as to provide a scientific basis for prevention and control of hypertension in the pediatric population.
Methods:
From March to December 2019, using stratified cluster random sampling, 3 626 children and adolescents aged 6-17 years without elevated blood pressure at baseline were recruited from 6 primary and secondary schools in Guangzhou. Serum uric acid levels were measured at baseline, and divided into four groups ( Q1-Q 4) based on age and sex specific quartiles for analyses. Two waves of follow up were carried out from October 2020 to May 2021 and from October 2021 to May 2022, respectively. Multilevel robust Poisson regression was used to evaluate the association between uric acid level and elevated blood pressure among children and adolescents. The additive interaction between high uric acid level and sugar sweetened beverage (SSB) intake on elevated blood pressure was assessed by stratification analysis and calculation of the relative excess risk due to interaction (RERI).
Results:
A total of 1 131 new cases of elevated blood pressure were identified during the two follow ups, with an incidence density of 130.5 cases 1 000 person years. Multilevel robust Poisson regression analysis showed that after adjusting for confounders such as gender, age and annual family income, compared with those in the uric acid Q 1 level, the risk of elevated blood pressure in individuals in the Q 4 level increased by 25% ( RR=1.25, 95%CI =1.08-1.44), and the risk of elevated systolic blood pressure increased by 20% ( RR=1.20, 95%CI =1.05-1.36) (both P <0.05); no statistical association was observed between uric acid and elevated diastolic blood pressure (all P >0.05). In the stratified analysis, the statistical associations of uric acid Q 4 level with elevated blood pressure ( RR=1.34, 95%CI =1.13-1.58) and elevated systolic blood pressure ( RR=1.33, 95%CI =1.14-1.55) were only observed in the group with SSB intake ≥ 250 mL/week (both P <0.05). The RERI values for the effect of uric acid Q 4 and Q 3 levels with SSB intake ≥ 250 mL/week on elevated systolic and diastolic blood pressure were 0.29 and 0.44 (both P <0.05).
Conclusions
High uric acid level is a risk factor for elevated blood pressure among children and adolescents, with a predominant effect on systolic blood pressure. High uric acid level and SSB intake synergistically promote the increase of blood pressure of children and adolescents.
4.Research progress on traditional Chinese medicine remodeling the immune microenvironment in ischemic stroke by regulating HIF-1α-mediated glycolytic reprogramming
Jiayu DU ; Senyu WANG ; Chen BAI ; Yingxu HAO ; Xiangzhe LIU
China Pharmacy 2026;37(17):2332-2337
Ischemic stroke (IS) is a serious cerebrovascular disease with high clinical incidence. Cerebral ischemia and hypoxia can induce metabolic reprogramming of cellular glycolysis. Hypoxia-inducible factor-1α (HIF-1α) serves as the core transcription factor in the hypoxic response. This article systematically reviews the molecular mechanisms of HIF-1α-mediated glycolytic reprogramming, elaborates on the effects of this metabolic alteration on the functional status of different immune cells, and summarizes the research progress of traditional Chinese medicine (TCM) interventions in this pathological process. HIF-1α reshapes glucose metabolic flux and shifts cellular metabolism toward glycolysis by regulating the transcription of key genes, including glucose transporters, glycolytic rate-limiting enzymes, and mitochondrial oxidative inhibitors. This metabolic disturbance can regulate the activation status, phenotypic differentiation, and functional remodeling of microglia, astrocytes, and peripherally infiltrated immune cells, thereby participating in the mediation of neuroinflammatory responses after IS. Moreover, multiple signaling pathways and the metabolite of glycolysis lactate can exert feedback regulation on this metabolic-immune process. Various active components of TCM and herbal formulas, such as astragaloside Ⅳ, salvianolic acid C, Ginkgo biloba extract, and Mailuo shutong pills, can inhibit abnormal glycolysis, reduce lactate accumulation, and restore the homeostasis of glucose oxidative metabolism by regulating signaling pathways including AMP-activated protein kinase/mammalian target of rapamycin/HIF-1α, HIF-1α/pyruvate kinase M2, and HIF-1α/lactate dehydrogenase A. Consequently, they effectively alleviate neuroimmune inflammation and attenuate ischemic brain injury.
5.Efficacy and safety of different classes of antibacterial agents for hospitalized adult patients with community-acquired pneumonia:a network meta-analysis
Tianqi LIU ; Ruixue LI ; Zinan ZHAO ; Wenfeng XU ; Zi LIANG ; Jiayu ZHANG ; Ting LI ; Pengfei JIN
China Pharmacy 2026;37(18):2442-2448
OBJECTIVE To compare the efficacy and safety of different classes of antibacterial agents in hospitalized adult patients with community-acquired pneumonia (CAP).METHODS PubMed, Embase,the Cochrane Library,Web of Science,CNKI,and Wanfang data were searched from inception to January 1,2026,to identify randomized controlled trials that evaluated different classes of antibacterial agents in hospitalized adults with CAP.After screening the literature, extracting the data, and evaluating the quality of the literature, a network meta-analysis was performed using Stata 18.0.RESULTS A total of 25 studies were included,involving 7 863 patients. In terms of efficacy,compared with carbapenems,penicillins,cephalosporins,macrolides,and pleuromutilins were associated with significantly higher treatment failure rates ( P <0.05),carbapenems and traditional tetracyclines were ranked as the top two by the surface under the cumulative ranking curve area (SUCRA). No statistically significant differences were observed in mortality among the interventions ( P >0.05),carbapenems and other quinolones were ranked as the top two by SUCRA. In terms of safety,no statistically significant differences were observed among the interventions in the incidence of adverse events or discontinuation rates ( P >0.05);traditional tetracyclines and novel tetracyclines were ranked as the top two by SUCRA for the incidence of adverse events,while novel tetracyclines and pleuromutilins were ranked as the top two by SUCRA for discontinuation rates.CONCLUSIONS Carbapenems significantly reduced the treatment failure rate in hospitalized adults with CAP. The safety profiles of all antibacterial agents were comparable, with novel tetracyclines showing a more favorable safety profile.
6.Construction of a realistic tumor cell surface model and dose estimation under irradiation conditions
Yunan GAO ; Yuan ZHUANG ; Jiayu WU ; Jiayue LIU ; Yixing CHEN
Chinese Journal of Radiation Oncology 2025;34(10):1014-1019
Objective:To construct a realistic surface model of human glioma T98G cells, aiming to enhance the accuracy of dose assessment at the cellular level in radiotherapy.Methods:Three-dimensional tomographic images of T98G cells were acquired using a laser confocal microscope. Subsequently, after cropping via MATLAB software and conversion to the DICOM format, the Amira and Meshmixer softwares were employed to repair and reconstruct the authentic curved - surface models of the cell nucleus and cytoplasm. The GATE Monte Carlo simulation platform was utilized to construct the 160 kV X ray energy spectrum of the RS - 2000 Pro irradiator. In a vacuum environment, the energy deposition processes of single cells and cell populations were simulated, and the dose distributions of the cell nucleus and cytoplasm were computed.Results:In the single cell simulation, the absorbed dose of the cell nucleus was 0.07 Gy, and 0.23 Gy for the cytoplasm. Under the same irradiation duration, the dose of the cell nucleus accounted for approximately 70% of the external irradiation dose. The calculated standard deviations of absorbed dose were 3.03×10?? and 5.73×10?? Gy, respectively, indicating a notable randomness in dose deposition. Since 2 Gy is a widely-adopted dose in radiotherapy fractionation regimens, cell populations were irradiated with 2 Gy. The findings revealed that the internal dose distribution of cell populations exhibited a non-Gaussian distribution, demonstrating the randomness of dose deposition. Specifically, the dose of the cell nucleus was concentrated in the range of 0.6-1.8 Gy, and the dose of the cytoplasm was concentrated in the range of 0.9-2.7 Gy.Conclusions:A curved- surface model of human glioma cells is successfully constructed, which can lay a foundation for improving the accuracy of microscopic dosimetry simulation.
7.Research progress on assessment tools for health behavior motivation in patients with cardiovascular diseases
Zhifeng ZHANG ; Lei LIU ; Yikang XU ; Daqiu WANG ; Jiayu WANG ; Yu TIAN ; Kaiwen ZHAN ; Siqi SUN ; Manman LI
Journal of Shenyang Medical College 2025;27(2):198-201
Health behavior motivation significantly affects the quality of life of patients with cardiovascular diseases.Assessing the level of health behavior motivation can measure the health behavior of individuals,help to promote the participation rate of cardiac rehabilitation,reduce the readmission rate of patients,and promote patients'healthy lifestyles.This article reviews the content,characteristics and application of assessment tools for health behavior motivation of patients with cardiovascular diseases at home and abroad,with the aim of providing references for the development and application of such tools in China,and offering a basis for scientifically assessing their health behavior motivation level and formulating effective strategies to promote health behavior motivation.
8.Research progress on assessment tools for the treatment burden of patients with chronic diseases
Kaiwen ZHAN ; Lei LIU ; Daqiu WANG ; Jiayu WANG ; Yu TIAN ; Manman LI ; Siqi SUN ; Zhifeng ZHANG
Journal of Shenyang Medical College 2025;27(1):74-78
The number of patients with chronic diseases in China has been increasing year by year,followed by the increase of treatment burden.It is particularly important to effectively evaluate the treatment burden of patients with chronic diseases.This paper reviews the main contents,application scope,advantages and disadvantages of the assessment tools for the treatment burden of patients with chronic diseases at home and abroad,so as to provide references and basis for medical staff to reasonably select assessment tools and conduct relevant clinical research.
9.A comparative study of depression phenotype in a tumor-bearing mouse model of breast cancer
Xiaofei LI ; Ke JIANG ; Mengting DONG ; Yuelian WANG ; Jiaqi LIU ; Xin LI ; Jiayu SHENG
Acta Laboratorium Animalis Scientia Sinica 2025;33(2):232-240
Objective Compare the depression phenotypes of a breast cancer tumor-bearing mouse model constructed using two different method and a mouse model of breast cancer depression with clinical manifestations,as well as assess their suitability for basic research.Methods We constructed a tumor model with 4T1 breast cancer cells alone(4T1 group)and a tumor-depression composite model given chronic unpredictable mild(CUMS)(4T1+CUMS group).The experimental period was 42 d,and the body mass,tumor volume,and survival time of the mice were monitored throughout the whole process.Two depressive behavioral tests(of sucrose preference test,open field test,tail suspension test,and elevated plus maze)were performed on the 15th and 29th days,respectively.Hematoxylin-eosin(HE)staining was used to observe the pathological changes of hippocampal neurons in brain tissue sections.Results(1)Body mass:The body mass of the 4T1 group and 4T1+CUMS group began to decrease from 29 d,and the body mass of the 4T1+CUMS group was significantly lower than that of the 4T1 group and Control group at the end of the experiment(P<0.001).(2)Tumor volume:There was no significant difference in the growth rate of tumors between the two model groups throughout the experiment(P>0.05).(3)Survival time:The survival rates of the 4T1 group and 4T1+CUMS group were 100%and 60%,and the first death of mice in the 4T1+CUMS group was on the 36th day.(4)Behavior test of depression:There was no significant difference between the three groups in the first depressive behavior tests(P>0.05),and the two groups showed obvious depressive phenotypes in the second behavioral tests.The sucrose preference index and activity distance in the central area were significantly decreased in the two model groups(P<0.001),and the immobility time was significantly increased(P<0.001).(5)Pathological section of brain tissue:On pathological examination of brain tissue,we observed a reduced number of neuronal cells in the hippocampus of the 4T1 group and 4T1+CUMS group,their morphology was irregular,the arrangement between the cells was disordered and the gap was unclear,and some nucleoli were blurred.Conclusions Although the tumor-only method and the tumor with compound stress stimulation method can both be used to prepare breast cancer depression models,the tumor-only modeling method is simpler and the mortality rate after successful modeling is higher.The long window of time is convenient for subsequent drug administration and detection,and the causes of the depression phenotype are more in line with the clinical causes and manifestations.Therefore,the 4T1 model can provide a reference model for future animal experiments on breast cancer tumor-related depression.
10.Cytotoxic anthrone-cyclopentenone heterodimers from the fungus Penicillium sp. guided by molecular networking.
Ruiyun HUO ; Jiayu DONG ; Gaoran LIU ; Ying SHI ; Ling LIU
Chinese Journal of Natural Medicines (English Ed.) 2025;23(10):1259-1267
(±)-Penicithrones A-D (1a/1b-4a/4b), four novel pairs of anthrone-cyclopentenone heterodimers characterized by a distinctive bridged 6/6/6-5 tetracyclic core skeleton, together with three previously identified compounds (5-7), were isolated from the crude extract of the mangrove-derived fungus Penicillium sp., guided by heteronuclear single quantum correlation (HSQC)-based small molecule accurate recognition technology (SMART 2.0) and liquid chromatography-tandem mass spectrometry (LC-MS/MS)-based molecular networking. The structural elucidation of new compounds was accomplished through comprehensive spectroscopic analysis, and their absolute configurations were determined using DP4+ 13C nuclear magnetic resonance (NMR) calculations and electronic circular dichroism (ECD) calculations. Compounds 1a/1b-4a/4b demonstrated moderate cytotoxicity against three human cancer cell lines HeLa, HCT116 and MCF-7 with half maximal inhibitory concentration (IC50) values ranging from 15.95 ± 1.64 to 28.56 ± 2.59 μmol·L-1.
Humans
;
Penicillium/chemistry*
;
Molecular Structure
;
Cyclopentanes/isolation & purification*
;
Cell Line, Tumor
;
Antineoplastic Agents/pharmacology*
;
Tandem Mass Spectrometry
;
Dimerization
;
HeLa Cells
;
Magnetic Resonance Spectroscopy


Result Analysis
Print
Save
E-mail